FindTrial
Sign In

Analysis of healthcare resource utilization and total socioeconomic burden among RBC transfusion dependent patients with MDS in South Korea

Analysis of healthcare resource utilization and total socioeconomic burden among RBC transfusion dependent patients with MDS in South Korea

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0010062
Enrollment
500
Registered
2024-12-18
Start date
2023-01-31
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Samsung Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients will be included in the study if all the following criteria are met: • A patient who is at 18 years if age or older with a documented diagnosis of MDS (ICD-10 code of D46) from September 1st 1994 to April 1st 2022 at SMC. • A patient who has had healthcare resource utilization (HCRU) data at SMC.

Exclusion criteria

Exclusion criteria: Any patient who was diagnosed with documented AML or confirmed to have = 20% blasts in the bone marrow or peripheral blood within one month after the index date will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
Disease burden of RBC transfusion dependence in myelodysplastic syndromes as identified in terms of healthcare resource use and medical costs—

Secondary

MeasureTime frame
Clinical outcomes as identified in terms of survival data including overall survival, leukemia-free survival, and progression-free survival—

Countries

Korea, Republic of

Contacts

Public ContactJun Ho Jang

Samsung Medical Center

smcjunhojang@gmail.com+82-2-3410-6250

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026